4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001209191-22-035848
Chief Executive Officer acquired 5,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Seehra Jasbir Chief Executive Officer | 2022-06-09 | Option exercise | +5,000 | $0.30 | $1,500 | 248,856 | D |
| Derivatives | |||||||
| Seehra Jasbir Chief Executive Officer | 2022-06-09 | Option exercise · Employee Stock Option (right to buy) | −5,000 | 8,822 | D | ||
Loading xslF345X03/doc4.xml…